EUVIMEDEUVIMED entdecken
Crossref

The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris

Vivien Hébert, Julien Novarino, Maud Maho-Vaillant, Corine Perals, Sébastien Calbo, Marie-Laure Golinski, Fanny Martinez, Pascal Joly, Nicolas Fazilleau

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Vivien Hébert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, French Reference Center for Auto Immune Blistering Diseases, Rouen University Hospital, Normandie University, Rouen, Franc…. Hauptthemen laut MEDLINE: Pemphigus, Desmoglein 3, T-Lymphocytes, Regulatory, Rituximab. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: French Society of Dermatology, Region Occitanie/Pyrénées-Méditerranée, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pemphigus vulgaris (PV) is characterized by autoantibodies targeting keratinocyte adhesion proteins desmoglein (Dsg) 1 and 3, and by the human leukocyte antigen (HLA) predisposition allele HLA-DRB1*0402. Treatment using rituximab (RTX) combined with short-term corticosteroids (CS) allows disease control and long-lasting remission.

Objectives

The principal aim of this study was to evaluate the impact of RTX on the circulating subpopulations of Dsg3-specific T lymphocytes that specifically regulate B-cell responses: follicular helper T (Tfh) and follicular regulatory T (Tfr) lymphocytes.

Methods

Using the HLA-DRB1*0402 tetramer loaded with the Dsg3 immunodominant peptide, we used flow cytometry to analyse the frequency, polarization and activation status of blood Dsg3-specific follicular T-cell populations at baseline, month (M) 6 and long-term follow-up (M60–90) from patients with PV.

Results

At baseline, we observed a predominance of Tfh1* and Tfh17 subsets and an underrepresentation of the Tfh2 subset among autoreactive Dsg3-specific Tfh cells compared with nonautoreactive Tfh cells. RTX treatment induced a decrease of autoreactive Tfh cells with no effect on their polarization during follow-up. In parallel, we observed the emergence of a Dsg3-specific Tfr subpopulation with a significant overexpression of the surface activation markers PD1, ICOS and CD25 that was not observed at the surface of autoreactive Tfh and nonautoreactive Tfr cells of the same patients with PV. In contrast, very few Dsg3-specific Tfr cells were observed in patients with PV who were treated with CS alone.

Conclusions

Here we show that the emergence of circulating autoreactive Dsg3-specific Tfr cells is associated with the long-term efficacy of RTX in patients with PV. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PemphigusDesmoglein 3T-Lymphocytes, RegulatoryRituximabAutoantibodiesHumansMaleFemaleMiddle AgedTreatment OutcomeAdultAgedImmunologic FactorsT-Lymphocytes, Helper-InducerHLA-DRB1 ChainsLymphocyte Activation

Substanzen

Desmoglein 3RituximabAutoantibodiesDSG3 protein, humanImmunologic FactorsHLA-DRB1 Chains

Autor:innen und Institutionen

  • Department of Dermatology, French Reference Center for Auto Immune Blistering Diseases, Rouen University Hospital, Normandie University, Rouen, France.
  • Normandie University, UNIROUEN, Inserm, U1234, FOCIS Center of Excellence PAn'THER, Rouen University Hospital, Department of Immunology and Biotherapy, Rouen, France.
  • INFINITy, Toulouse Institute for Infectious and Inflammatory Diseases, INSERM U1291, CNRS U5051, University Toulouse III, Toulouse, France.

Förderung

  • French Society of Dermatology
  • Region Occitanie/Pyrénées-Méditerranée
  • European Regional Development Fund
  • National Research Agency

Zitieren

APA

Hébert, V., Novarino, J., Maho-Vaillant, M., Perals, C., Calbo, S., Golinski, M. L., Martinez, F., Joly, P., & Fazilleau, N. (2024). The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae220

Vancouver

Hébert V, Novarino J, Maho-Vaillant M, Perals C, Calbo S, Golinski ML, et al. The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae220

BibTeX
@article{Hbert2024,
  author = {Hébert, Vivien and Novarino, Julien and Maho-Vaillant, Maud and Perals, Corine and Calbo, Sébastien and Golinski, Marie-Laure and Martinez, Fanny and Joly, Pascal and Fazilleau, Nicolas},
  title = {The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae220}
}
Kostenlos starten →